Building on the signaling cascades and mechanisms seen in cancer, we propose a novel role for FABP7 in sleep and AD pathogenesis in which ligand availability determines FABP7’s function, with DHA promoting neuroprotection and normal sleep, and AA promoting disrupted sleep and AD pathogenesis. Here, FABP7 is linked to Alzheimer disease.